Edgar Filing: Finley Sara

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Finley Sara

2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2010

3. Issuer Name and Ticker or Trading Symbol
CVS CAREMARK CORP [CVS]

(Last)

(First)

(Middle)

ONE CVS DRIVE

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
SVP, Gen Counsel

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

WOONSOCKET,Â RIÂ 02895

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,692 ⁽¹⁾	D	Â
Common Stock (restricted)	3,441 ⁽²⁾	D	Â
Common Stock (restricted)	7,287 ⁽³⁾	D	Â
Common Stock (restricted)	4,449 ⁽⁴⁾	D	Â
Common Stock (restricted)	21,860 ⁽⁵⁾	D	Â
Common Stock (restricted)	8,965 ⁽⁶⁾	D	Â
Common Stock (restricted)	3,644 ⁽⁷⁾	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	03/22/2007⁽⁸⁾	03/01/2015	Common Stock	183,165	$ 20.23	D	Â
Stock Option	03/22/2007⁽⁸⁾	03/01/2016	Common Stock	131,158	$ 27.12	D	Â
Stock Option	04/02/2007⁽⁹⁾	04/02/2014	Common Stock	125,250	$ 34.42	D	Â
Stock Option	04/01/2009⁽¹⁰⁾	04/01/2015	Common Stock	51,892	$ 41.17	D	Â
Stock Option	04/01/2009⁽¹¹⁾	04/01/2016	Common Stock	53,531	$ 28.1	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Finley Sara ONE CVS DRIVE WOONSOCKET,Â RIÂ 02895	Â	Â	Â SVP, Gen Counsel	Â

Signatures

Sara J. Finley		02/01/2010
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes shares acquired through the participation in the Issuer's Employee Stock Purchase Plan.
(2)	Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/18/2010.
(3)	Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2012.
(4)	Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2013.
(5)	Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 3/22/2010.
(6)	Consists of Restricted Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.
(7)	Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2012.
(8)	Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of merger.
(9)	Option became exercisable in three equal annual installments on 4/2/2008.
(10)	Option became exercisable in three equal annual installments on 4/1/2009.
(11)	Option becomes exercisable in three equal annual installments, commencing 4/1/2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.